STRYKER CORP
No SEC Form 4 filings for $SYK in the last 30 days.
Stryker (NYSE:SYK) said its board declared a quarterly cash dividend of $0.88 per share. The dividend is payable Oct. 30, 2026, to shareholders of record as of Sept. 30, 2026. The company noted this is up 4.8% from the prior year and unchanged from the previous quarter.
Stryker (SYK) reported Q2 2026 adjusted EPS of $3.69, up 17.9% year over year, with organic net sales up 9% and adjusted gross margin at 66%. Management cited recovery from a prior cybersecurity incident and higher production. Full-year organic net sales guidance is 8.3% to 9.3%, and adjusted EPS guidance is $14.95 to $15.10.
UBS lowered its price target on Stryker (SYK) to $382 from $400 while keeping a Buy rating, according to the note cited in the article. The stock is shown trading around $341.20 at market close on Aug. 3, 2026.
Over the past 7 days, alphai's AI scored 5 news stories mentioning SYK (STRYKER CORP). Coverage has skewed bullish: 2 bullish, 2 neutral, and 1 bearish.
Recent SYK coverage spans earnings, financial news and market movers.
Dividend increase is a modest, shareholder-return signal but not a fundamental earnings or guidance change.
Guidance narrowing plus margin expansion signals improving operating leverage after the prior cybersecurity incident, but peripheral vascular backorders remain a near-term risk.
The update is a sell-side valuation reset without new company fundamentals in the text.
The article frames a post-earnings valuation gap versus a stated fair value, but highlights margin risk from supply chain issues and potential European regulatory delays.
The piece frames the post-earnings selloff as a valuation-discount question, but it does not add new guidance beyond the reported results and analyst target range.
alphai scores every news story that mentions SYK with an AI model for sentiment and relevance, and aggregates insider trades from STRYKER CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Stryker (NYSE:SYK) said its board declared a quarterly cash dividend of $0.88 per share. The dividend is payable Oct. 30, 2026, to shareholders of record as of Sept. 30, 2026. The company noted this is up 4.8% from the prior year and unchanged from the previous quarter.
1 min readStryker (SYK) reported Q2 2026 adjusted EPS of $3.69, up 17.9% year over year, with organic net sales up 9% and adjusted gross margin at 66%. Management cited recovery from a prior cybersecurity incident and higher production. Full-year organic net sales guidance is 8.3% to 9.3%, and adjusted EPS guidance is $14.95 to $15.10.
6 min readUBS lowered its price target on Stryker (SYK) to $382 from $400 while keeping a Buy rating, according to the note cited in the article. The stock is shown trading around $341.20 at market close on Aug. 3, 2026.
1 min readSimply Wall St reports Stryker (NYSE:SYK) Q2 2026 results: sales of $6.6b and net income of $1.3b, with higher EPS from continuing operations. The stock fell 6.42% to $325.70 after results. The article cites a fair value of $386.80 (about 16% upside) but notes risks from European regulatory delays and supply chain issues.
4 min readSimply Wall St reports Stryker (SYK) released 2Q 2026 results with sales of $6.59b and net income of $1.28b. The stock fell 6.42% on the earnings day and is about 23% below one valuation estimate and 18% below the average analyst target. Consensus price target is $386.8, with a range from $465 to $315.
6 min readTipRanks highlights analyst rating changes for Intuit (INTU), Alphabet (GOOGL), Honeywell (HON), Becton Dickinson (BDX) and Stryker (SYK). Intuit was cut to Hold with a $304 target. Alphabet was upgraded to Buy, $425 target, after 2Q26 revenue +24% and cloud revenue +82%. Honeywell upgraded to Neutral, $265 target. BDX initiated Buy, $190 target. Stryker upgraded to Buy, $400 target.
4 min readStryker (SYK) shares fell about 6% to around $325 after its Q2 results. The company reported adjusted EPS of $3.69 and 9% organic sales growth. Adjusted gross margin was 66% and adjusted operating margin 27.4%. Q2 revenue rose to $6,589 million and guidance called for 8.3% to 9.3% organic growth and EPS $14.95 to $15.10.
5 min readStryker’s Q2 outlook update cites supply chain disruptions affecting growth, even as margins are expected to expand. Management says revenue acceleration depends on converting a backlog of capital equipment orders and improving peripheral vascular backorder recovery. Profitability may be pressured by cybersecurity remediation, higher production costs, and raw material volatility. Stryker shares were $321.25 after falling from $348.10 pre-earnings.
4 min readStryker (SYK) reported Q2 2026 sales of $6.59B and net income of $1.28B, lifting basic EPS from continuing operations to $3.32. Management slightly raised full-year guidance, resumed share repurchases, and cited recovery from a March cyberattack. The article also notes a $32.6B revenue and $6.5B earnings outlook by 2029.
5 min readStryker (SYK) shares fell about 7.3% in the morning after the company reported Q2 results. Revenue rose 9.4% year over year to $6.59 billion, but organic growth of about 9% met only Wall Street expectations and missed forecasts. Adjusted earnings were $3.69 per share, beating estimates by 5.8%, and guidance was slightly raised.
5 min read
